Colorectal Cancer Clinical Trials in San Antonio

Showing 181-200 of 248 trials

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

NCT04006301

The purpose of this study is to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of JNJ-74699157 in participants with advanced solid tumors harboring a kirsten rat sarcoma virus homolog (KRAS) glycine-to-cysteine (G12C) mutation (Part 1: Dose escalation) and to determine the safety and preliminary antitumor activity of JNJ-74699157 at the RP2D regimen in participants with advanced solid tumors harboring a KRAS G12C mutation (Part 2: Dose expansion).

NeoplasmsAdvanced Solid TumorsNon-small Cell Lung Cancer+1 more

Janssen Research & Development, LLC10 participantsStarted Jul 2019

Sarasota, Florida, United States • Tampa, Florida, United States • Nashville, Tennessee, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Study in Second Line Metastatic Colorectal Cancer

NCT01183780

The purpose of this study is to compare overall survival in participants with metastatic colorectal cancer treated with either ramucirumab and FOLFIRI or placebo and FOLFIRI.

Colorectal Cancer

Eli Lilly and Company1,072 participantsStarted Dec 2010

Sedona, Arizona, United States • Tucson, Arizona, United States • Fayetteville, Arkansas, United States +210 more locations

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

A Study in Second Line Metastatic Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Sym004 in Patients With Advanced Solid Tumors

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer

Study of Ruxolitinib in Colorectal Cancer Patients

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Other Conditions in San Antonio